The Five Year Desert to Product Market Fit and a $5.3BN Valuation | Shiv Rao, Founder @ Abridge
Harry Stebbings interviews Shiv Rao, founder and CEO of Abridge, about the company's journey from a five-year "wilderness" to a $5.3BN valuation in vertical AI for healthcare. They discuss critical lessons on market timing, fundraising, unique company values, navigating the complex healthcare enterprise market, and Abridge's strategy for building proprietary AI models alongside leveraging frontier technology. Rao also shares insights on leadership, talent acquisition, and balancing a demanding founder role with family life.
- Abridge, the healthcare AI unicorn now valued at $5.3 billion, operates on a core value: "you have to taste good things to have good taste," conceived years before "taste" became a trend. Read →
- Abridge founder Shiv Rao navigated a challenging five-year "wilderness" period before his company achieved its current $5.3 billion valuation in vertical AI for healthcare. Read →
- Abridge, the $5.3BN vertical AI company, generates 40% of its AI outputs from models built entirely in-house. Read →
- Abridge founder Shiv Rao didn't just chase big names for his healthcare AI startup; he prioritized "founder-partner fit" over mere firm prestige. Read →
- Abridge, founded by Shiv Rao, achieved a $5.3BN valuation by building an "intelligence layer" for healthcare AI, specifically avoiding direct competition with EMR giants like Epic. Read →
- Healthcare in the US isn't one giant market; it's a collection of many distinct, segmented markets, each needing a tailored approach. Read →
- After a five-year "wilderness," Abridge's $5.3BN valuation shows that market timing and founder tenacity are non-negotiable. Rao's journey underscores the founder's role in the long game. Read →